NZ185539A - Cis-4a-aryl-2-substituted-2,3,4,4a,5,6,7,7a-octa hydro-1h-2-pyrindines and pharmaceutical compositions - Google Patents

Cis-4a-aryl-2-substituted-2,3,4,4a,5,6,7,7a-octa hydro-1h-2-pyrindines and pharmaceutical compositions

Info

Publication number
NZ185539A
NZ185539A NZ185539A NZ18553977A NZ185539A NZ 185539 A NZ185539 A NZ 185539A NZ 185539 A NZ185539 A NZ 185539A NZ 18553977 A NZ18553977 A NZ 18553977A NZ 185539 A NZ185539 A NZ 185539A
Authority
NZ
New Zealand
Prior art keywords
pyrindines
cis
aryl
substituted
pharmaceutical compositions
Prior art date
Application number
NZ185539A
Other languages
English (en)
Inventor
D Zimmerman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NZ185539A publication Critical patent/NZ185539A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/757Unsaturated compounds containing a keto groups being part of a ring containing —CHO groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
NZ185539A 1976-11-02 1977-10-27 Cis-4a-aryl-2-substituted-2,3,4,4a,5,6,7,7a-octa hydro-1h-2-pyrindines and pharmaceutical compositions NZ185539A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73795876A 1976-11-02 1976-11-02

Publications (1)

Publication Number Publication Date
NZ185539A true NZ185539A (en) 1979-12-11

Family

ID=24965981

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ185539A NZ185539A (en) 1976-11-02 1977-10-27 Cis-4a-aryl-2-substituted-2,3,4,4a,5,6,7,7a-octa hydro-1h-2-pyrindines and pharmaceutical compositions

Country Status (26)

Country Link
JP (1) JPS5356669A (xx)
AR (1) AR223454A1 (xx)
AT (1) ATA782177A (xx)
AU (1) AU513679B2 (xx)
BE (1) BE860314A (xx)
CA (1) CA1100136A (xx)
CS (1) CS211380B2 (xx)
DD (1) DD133795A5 (xx)
DE (1) DE2748466A1 (xx)
DK (1) DK485277A (xx)
ES (3) ES463784A1 (xx)
FR (1) FR2369267A1 (xx)
GB (1) GB1590155A (xx)
GR (1) GR70053B (xx)
HU (1) HU176231B (xx)
IE (1) IE45901B1 (xx)
IL (1) IL53236A0 (xx)
NL (1) NL7712053A (xx)
NZ (1) NZ185539A (xx)
PH (1) PH12590A (xx)
PL (3) PL108466B1 (xx)
PT (1) PT67194B (xx)
RO (3) RO77935A (xx)
SE (3) SE7712218L (xx)
SU (3) SU812174A3 (xx)
ZA (1) ZA776497B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ189230A (en) * 1977-12-27 1981-05-15 Lilly Co Eli Trans-4a-aryl-2-substituted-octahydro-1h-2-pyrindines
US4277608A (en) * 1979-06-21 1981-07-07 Eli Lilly And Company Method of preparing 4a-arylhexahydro-1H-2-pyrindines and 4a-aryloctahydroisoquinolines
US4236009A (en) * 1979-06-21 1980-11-25 Eli Lilly And Company Method of preparing 4A-arylhexahydro-1H-2-pyrindines and 4A-aryloctahydroisoquinolines
ZA9510829B (en) * 1994-12-23 1996-07-03 Smithkline Beecham Corp 3,3-(disubstituted)cyclohexan-1-one monomers and related compounds
HUE028983T2 (en) 2010-05-06 2017-01-30 Vertex Pharma Heterocyclic chromene-spirocyclic piperidine amides as ion channel modulators
EP3056495A1 (en) 2011-02-02 2016-08-17 Vertex Pharmaceuticals Inc. Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
US10385070B2 (en) 2011-02-18 2019-08-20 Vertex Pharmaceuticals Incorporated Chroman-spirocyclic piperidine amides as modulators of ion channels
WO2012125613A1 (en) 2011-03-14 2012-09-20 Vertex Pharmaceuticals Incorporated Morpholine-spirocyclic piperidine amides as modulators of ion channels

Also Published As

Publication number Publication date
PT67194B (en) 1979-03-23
SE8103107L (sv) 1981-05-18
FR2369267B1 (xx) 1980-05-16
BE860314A (fr) 1978-04-28
DK485277A (da) 1978-05-03
GB1590155A (en) 1981-05-28
ES463783A1 (es) 1979-07-16
PL108610B1 (en) 1980-04-30
GR70053B (xx) 1982-07-26
PT67194A (en) 1977-11-01
IE45901B1 (en) 1982-12-29
PL201885A1 (pl) 1978-12-04
IE45901L (en) 1978-05-02
SU812174A3 (ru) 1981-03-07
HU176231B (en) 1981-01-28
CA1100136A (en) 1981-04-28
RO78300A (ro) 1982-04-12
AR223454A1 (es) 1981-08-31
NL7712053A (nl) 1978-05-05
SE8103106L (sv) 1981-05-18
ES463784A1 (es) 1978-06-16
ATA782177A (de) 1981-10-15
AU513679B2 (en) 1980-12-18
PL109690B1 (en) 1980-06-30
SU845777A3 (ru) 1981-07-07
RO77935A (ro) 1981-12-25
RO72900A (ro) 1981-11-04
ES472276A1 (es) 1979-10-01
DE2748466A1 (de) 1978-05-03
PH12590A (en) 1979-06-27
FR2369267A1 (fr) 1978-05-26
SE7712218L (sv) 1978-05-03
JPS5356669A (en) 1978-05-23
AU3023577A (en) 1979-05-10
SU913941A3 (en) 1982-03-15
DD133795A5 (de) 1979-01-24
CS211380B2 (en) 1982-02-26
ZA776497B (en) 1979-06-27
IL53236A0 (en) 1977-12-30
PL108466B1 (en) 1980-04-30

Similar Documents

Publication Publication Date Title
PH13563A (en) 2,6-diaminonebularines and compositions thereof
NZ190299A (en) 1,2,4-trizole -3,5- diamines and pharmaceutical compositions
NZ185986A (en) 2-oxa-bicyclic prostag-landins and pharmaceutical compositions
NZ190745A (en) Mercapto-substituted -2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutical compositions
NZ185965A (en) 5'-deoxy-5-fluor ocytidine, 5'-deoxy-5-fluoro-uridine and pharmaceutical compositions
NZ183551A (en) Aminochromanols and pharmaceutical compositions containingthem
NZ185358A (en) Spiro-hydantoins and pharmaceutical compositions
NZ183134A (en) I-i-(3-aryloxy-2-hydroxypropyl)-4-piperidyl-3-aryl-imid-azolidin or hexahydropyrimidin-2-ones; and pharmaceutical compositions
NZ184428A (en) N-acyl-l-alanyl-aminoacyl-amides untermediates and pharmaceutical compositions
IL51309A0 (en) New 1,2-benzisothiazolin-3-ones,their preparation and pharmaceutical compositions containing them
NZ188974A (en) 1,2,3,4,6,7,12,12b-octahydro(2,3-aquinolizine derivatives and pharmaceutical compositions
NZ184912A (en) 2-phenylamino-imidazolines and pharmaceutical compositions
NZ185539A (en) Cis-4a-aryl-2-substituted-2,3,4,4a,5,6,7,7a-octa hydro-1h-2-pyrindines and pharmaceutical compositions
NZ185909A (en) 1,5-dusubstituted hydantois (or 2-thiohydantoins)and pharmaxeutical compositions
NZ189881A (en) 4,5-diaryl-2-(substituted-thio)-pyrroles and pharmaceutical compositions
NZ184529A (en) 5-isopropylidene-7-hydroxy-9-substituted-2,6-methano-3,4,56-tetrahydro-2h-1-benzoxocins and their preparation
NZ184185A (en) 3,5,5-trimethylhexanoyl-ferrocene and pharmaceutical compositions
NZ183549A (en) Amidinopencillanoyloxy-alkyl-amoxycillinates and pharmaceutical compositions
NZ183756A (en) Bis-penicillanoyloxy-alkanes and pharmaceutical compositions
IL55869A (en) 2,4-diamino-5-benzylpyrimidines,their manufacture and pharmaceutical compositions containing them
NZ183075A (en) 2,2-disubstituted-5-phenyl-carbamoyl-6-hydroxy-m-dioxin-4-ones and insecticidal compositions
NZ185996A (en) 6, 7-methylene-3-oxo-d-homo-17a-pregna-4, 16-dienes and pharmaceutical compositions
NZ183436A (en) Substituted phenylguanidines and pharmaceutical compositions
IL54001A0 (en) 2,4-dichlorophenyl-imidazolyl-ethan-ones and -ols, their preparation and pharmaceutical compositions containing the
ZA777358B (en) Pharmaceutical compositions and methods